|
Volumn 20, Issue 3, 2002, Pages 183-194
|
Development of an economic model to assess the cost effectiveness of asthma management strategies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BECLOMETASONE DIPROPIONATE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
CORTICOSTEROID;
FLUTICASONE PROPIONATE;
PLACEBO;
SALMETEROL;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DOUBLE BLIND PROCEDURE;
DRUG COST;
DRY POWDER;
HEALTH CARE COST;
HEALTH ECONOMICS;
HOSPITAL CARE;
HUMAN;
LUNG DISEASE;
MAJOR CLINICAL STUDY;
MODEL;
POWDER INHALER;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
PROBABILITY;
QUALITY ADJUSTED LIFE YEAR;
SCHOOL CHILD;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
EID: 0036235385
PISSN: 11707690
EISSN: None
Source Type: Journal
DOI: 10.2165/00019053-200220030-00004 Document Type: Article |
Times cited : (81)
|
References (17)
|